Alpa Laboratories Ltd.
NSE: ALPA | BSE: 532878
₹52.62
₹0.42
(0.80%)
As on 29-Oct-2026IST
Market cap
₹111 Cr
Revenue (TTM)
₹111 Cr
P/E Ratio
25.3
P/B Ratio
0.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹4 Cr
-
ROE
8.4 %
-
ROCE
9.4 %
-
Industry P/E
37.3
-
EV/EBITDA
13
-
Debt to Equity
0
-
Book Value
₹89
-
EPS
₹2.1
-
Face value
10
-
Shares outstanding
21,040,600
10 Years Aggregate
CFO
₹69.47 Cr
EBITDA
₹58.11 Cr
Net Profit
₹93.40 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Alpa Laboratories
| -32.3 | -11.1 | -20.7 | -41.1 | -10.1 | 0.8 | 2.4 |
|
BSE Healthcare
| 14.4 | -2.8 | -1.0 | 10.9 | 22.1 | 14.8 | 11.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Alpa Laboratories
| -37.5 | 14.0 | 64.0 | -20.7 | 117.8 | 120.4 | -34.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Alpa Laboratories
|
52.6 | 110.7 | 110.6 | 4.4 | -3.0 | 2.4 | 25.3 | 0.6 |
| 6,299.0 | 15,745.1 | 2,432.1 | 169.6 | 8.7 | 20.8 | 92.8 | 17.4 | |
| 680.9 | 7,260.7 | 1,074.2 | 166.5 | 18.5 | 13.1 | 45 | 5.9 | |
| 2,376.1 | 18,042.1 | 2,287.3 | 678.1 | 31.4 | 19.7 | 27.1 | 4.9 | |
| 2,217.4 | 13,547.3 | 1,479.1 | 198.6 | 18.6 | 30.3 | 68.1 | 16.8 | |
| 1,163.6 | 16,145.0 | 3,329.6 | 720.8 | 26.3 | 18.9 | 22.8 | 3.9 | |
| 3,759.8 | 17,203.0 | 2,569.8 | 735.2 | 34.4 | 19.2 | 23.4 | 3.9 | |
| 5,513.5 | 9,147.3 | 1,432.9 | 356.9 | 30.8 | 58.2 | 25.6 | 14.9 | |
| 935.6 | 18,288.9 | 1,682.5 | 273.5 | 21.0 | 11.1 | 61.5 | 6.8 | |
| 1,097.5 | 10,115.0 | 5,004.4 | 635.3 | 14.5 | 19.8 | 16.5 | 3.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Alpa Laboratories
Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It offers ethical, generic, and over the counter medicines. The company provides tablets, capsules, injections, syrups, ointments, creams, eye drops, and... other dosage forms for human and veterinary healthcare, as well as aquaculture products, including probiotics, deodorizer, minerals, feed supplements, and disinfectant. The company was founded in 1967 and is based in Indore, India. Read more
-
Incorporated
1988
-
Chairman
Mahendra Singh Chawla
-
Managing Director
Paresh Chawla
-
Headquarters
Indore Dist, Madhya Pradesh
-
Website
Looking for more details about Alpa Laboratories Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Alpa Laboratories
What is the current share price of Alpa Laboratories Ltd Today?
The share price of Alpa Laboratories Ltd is ₹52.62 (NSE) and ₹52.60 (BSE) as of 29-Oct-2026 IST. Alpa Laboratories Ltd has given a return of -10.07% in the last 3 years.
What is the current PB & PE ratio of Alpa Laboratories Ltd?
The P/E ratio of Alpa Laboratories Ltd is 25.28 times as on 29-Oct-2026, a 32 discount to its peers’ median range of 37.30 times.
The P/B ratio of Alpa Laboratories Ltd is 0.59 times as on 29-Oct-2026, a 88 discount to its peers’ median range of 4.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
6.48 |
0.52 |
2025 |
11.23 |
1.27 |
2024 |
10.46 |
1.16 |
2023 |
8.99 |
0.84 |
2022 |
10.38 |
1.20 |
What is the 52 Week High and Low of Alpa Laboratories Ltd?
The 52-week high and low of Alpa Laboratories Ltd are Rs 93.85 and Rs 46.10 as of 30-Oct-2026.
What is the market cap of Alpa Laboratories Ltd?
Alpa Laboratories Ltd has a market capitalisation of ₹ 111 Cr as on 29-Oct-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Alpa Laboratories Ltd?
Before investing in Alpa Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.